Skip to main content
SpringerLink
Log in

Quality of Life Measurements in Atopic Dermatitis

  • Chapter
Tacrolimus Ointment

  • 144 Accesses

Abstract

Patients and physicians alike have long been aware of the adverse effects skin disease can have on affected individuals, their families, partners, and friends. Attempts to document and measure these adverse effects are a recent phenomenon. The first quality-of-life (QoL) index designed for use with dermatology patients, specifically for those with psoriasis, was published in 1987 [12]. This chapter describes the concept of QoL measurement in dermatology, discusses several indices for use in dermatology and finally demonstrates how QoL indices have been employed to assess the response of patients with atopic dermatitis to various therapeutic modalities, particularly tacrolimus ointment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman AB (1995) Atopic dermatitis? In: Ackerman’s resolving quandaries in dermatology, pathology, and dermatopathology. Philadelphia, Promethean Medical Press, pp 17–21

    Google Scholar 

  2. Anderson RT, Rajagopolan R (1997) Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 36: 41–50

    Article  Google Scholar 

  3. Badia X, Mascaro JM, Lozano R (1999) Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensibility to change of the DLQI. Br J Dermatol 141: 698–702

    Article  PubMed  CAS  Google Scholar 

  4. Berth-Jones J, Finlay AY, Zaki I, Tan B et al. (1996) Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 34: 1016–1021

    Article  PubMed  CAS  Google Scholar 

  5. Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity and responsiveness. J Invest Derm 107: 707–713

    Article  PubMed  CAS  Google Scholar 

  6. Committee on Rating of Mental and Physical Impairment (1970) Guides to evaluation of permanent impairment: the skin. J Am Med Ass 211: 106–112

    Article  Google Scholar 

  7. Drake L, Prendergast M, Maher R, Breneman D et al. (2001) The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 44: S65–72

    Article  PubMed  CAS  Google Scholar 

  8. Emerson RM, Williams HC, Allen BR, Mehta R et al. (1997a) How much disability does atopic eczema cause compared to other common childhood health problems? Br J Dermatol 137 [Suppl 50]: 19

    Google Scholar 

  9. Emerson RM, Williams HC, Allen BR, Finlay AY (1997b) Childhood atopic dermatitis: a cause of significant morbidity in the community? J Invest Dermatol 108: 365

    Google Scholar 

  10. Emerson RM, Lawson S, Williams HC (1998) Do specialist eczema clinics benefit children with atopic dermatitis? Br J Dermatol 139 [Suppl 51]: 46

    Google Scholar 

  11. European Task Force on Atopic Dermatitis (1993) Severity scoring of atopic dermatitis. Dermatology 186: 23–31

    Article  Google Scholar 

  12. Finlay AY, Kelly SE (1987) Psoriasis — an index of disability. Clin Exp Dermatol 12: 8–11

    Article  PubMed  CAS  Google Scholar 

  13. Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI) — a simple practical measure for routine clinical use. Clin Exp Dermatol 19: 210–216

    Article  PubMed  CAS  Google Scholar 

  14. Finlay AY (1996a) Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 135: 509–515

    Article  PubMed  CAS  Google Scholar 

  15. Finlay AY (1996b) Measures of the effect of severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol 7: 149–159

    Article  Google Scholar 

  16. Finlay AY (1997) Quality of life measurement in dermatology: a practical guide. Br J Dermatol 136: 305–314

    Article  PubMed  CAS  Google Scholar 

  17. Finlay AY, Coles EC, Lewis-Jones MS, Blackford S et al. (1998) Quality of life improves after seeing a dermatologist. Br J Dermatol 139 [Suppl 51]: 15

    Google Scholar 

  18. Finlay AY (2001) Quality of life in atopic dermatitis. J Am Acad Dermatol 45: S64–66

    Article  PubMed  CAS  Google Scholar 

  19. Harlow D, Poyner T, Finlay AY, Dykes PJ (2000) Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 143: 979–982

    Article  PubMed  CAS  Google Scholar 

  20. Harper JI, Ahmed I, Barclay G, Lacour M et al. (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142: 52–58

    Article  PubMed  CAS  Google Scholar 

  21. Herd RM, Tidman MJ, Ruta DA, Hunter JAA (1997) Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol 136: 502–507

    Article  PubMed  CAS  Google Scholar 

  22. Jordan TE (1983) Developing an international index of quality of life for children: the NICQL Index. JR Soc Health 4: 127–130

    Article  Google Scholar 

  23. Kurwa HA, Finlay AY (1995) Dermatology in-patient management greatly improves life quality. Br J Dermatol 133: 575–578

    Article  PubMed  CAS  Google Scholar 

  24. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG (1998) The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 138: 107–113

    Article  PubMed  CAS  Google Scholar 

  25. Lewis-Jones MS, Finlay AY (1995) The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 132: 942–949

    Article  PubMed  CAS  Google Scholar 

  26. Lewis-Jones MS, Lawson V, Hill G, Reid P et al. (1996) Monitoring childhood skin disease impact. Br J Dermatol 135 [Suppl 47]: 52

    Google Scholar 

  27. Lewis-Jones MS, Finlay AY, Dykes PJ (2001) The Infants’ Dermatitis Quality of Life Index. Br J Dermatol 144: 104–110

    Article  PubMed  CAS  Google Scholar 

  28. Lindström B, Köhler L (1991) Youth, disability and quality of life. Paediatrician 18: 121–128

    Google Scholar 

  29. Linnet J, Jemec GBT (1999) An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 140: 268–272

    Article  PubMed  CAS  Google Scholar 

  30. Morgan M, McCreedy R, Simpson J, Hay RJ (1997) Dermatology quality of life scales: a measure of the impact of skin diseases. Br J Dermatol 136: 202–206

    Article  PubMed  CAS  Google Scholar 

  31. Pilleta PA, Wirth S, Hommel L, Saurat JH et al. (1996) Circulating skin-homing T cells in atopic dermatitis. Arch Dermatol 132: 1171–1177

    Article  Google Scholar 

  32. Price P, Harding KG (1993) Defining quality of life. J Wound Care 2: 304–306

    Google Scholar 

  33. Richman N, Graham PJ (1971) A behavioural screening questionnaire for use with three-year-old children. J Child Psychol Psychiatry 12: 5–33

    Article  PubMed  CAS  Google Scholar 

  34. Salek MS, Finlay AY, Luscombe DK, Allen BR et al. (1993) Cydosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomised, double-blind, placebo-controlled trial. Br J Dermatol 129: 422–430

    Article  PubMed  CAS  Google Scholar 

  35. von Reuden U, Staab D, Kehrt R, Wahn U (1998) Development of a questionnaire to measure health-related quality of life in parents of children with atopic dermatitis. Qual Life Res 7: 656–657

    Google Scholar 

  36. Whitmore CW (1970) Cutaneous impairment, disability and rehabilitation. Cutis 6: 989–992

    Google Scholar 

  37. World Health Organization (1980) International Classification of Impairments, Disabilities and Handicaps. WHO, Geneva, pp 27–29

    Google Scholar 

Download references

Authors
  1. A. Y. Finlay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. H. C. Burgdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Düsseldorf Hautklinik, Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Germany

    Thomas Ruzicka

  2. Hospital for Skin and Allergic Diseases, Department of Dermatology, Helsinki University Central Hospital, Meilahdentie 2, 00250, Helsinki, Finland

    Sakari Reitamo

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Finlay, A.Y., Burgdorf, W.H.C. (2004). Quality of Life Measurements in Atopic Dermatitis. In: Ruzicka, T., Reitamo, S. (eds) Tacrolimus Ointment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10209-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10209-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10211-4

  • Online ISBN: 978-3-662-10209-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation